Jolt Health Inc. operates as a licensee of technologies relating to substances and pharmaceutical grade therapeutics in Canada. It focuses on sexual health, with or without the benefit of CBD, acquired pursuant to various licenses. The company also offers CannaStrip, an oral muco-adhesive strips enhance the bioavailability of hemp oil extracts and THC, increasing the impact and duration of the health benefits; Arousel Gel, a topical gel infused with CBD and/or THC that increases genital blood flow causing vaginal engorgement/lubrication and clitoral engorgement/sensitivity; and CannaMint, a patent-protected technology that uses orally dissolvable mints to deliver CBD or THC for various conditions. In addition, it provides female sexual dysfunction supplement, a female sexual desire supplement; ToConceive, a vaginal moisturize; and male enhancement gel with CBD, a topical personal care penile gel. The company was formerly known as Love Pharma Inc. and changed its name to Jolt Health Inc. in May 2023. Jolt Health Inc. is headquartered in Vancouver, Canada.
Metrics to compare | JOLT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipJOLTPeersSector | |
---|---|---|---|---|
P/E Ratio | −0.5x | −0.9x | −0.5x | |
PEG Ratio | −0.36 | 0.00 | 0.00 | |
Price/Book | −0.5x | 0.7x | 2.6x | |
Price / LTM Sales | - | 0.8x | 3.3x | |
Upside (Analyst Target) | - | 117.4% | 41.6% | |
Fair Value Upside | Unlock | 5.8% | 5.9% | Unlock |